In agreement with the role of EGR1 in non-small cell lung cancers, breast cancer, glioblastomas, and acute myelogenous leukemia [6, 7, 28], our data support the hypothesis that EGR1 acts as a tumor suppressor in HCC. Here, EGR1 is linked to breast cancer.